Colchicine treatment can be discontinued in a selected group of pediatric FMF patients
Abstract Objectives Familial Mediterranean Fever (FMF) patients are required to adhere to a life-long treatment with colchicine, primarily for preventing amyloidosis. As some patients may be asymptomatic for long periods of time, it remains unclear whether it is possible to discontinue colchicine tr...
Saved in:
Main Authors: | Keren Cohen (Author), Shiri Spielman (Author), Rotem Semo-Oz (Author), Guy Bitansky (Author), Maya Gerstein (Author), Yonatan Yacobi (Author), Asaf Vivante (Author), Irit Tirosh (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2023-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effect of interleukin-1 antagonist on growth of children with colchicine resistant or intolerant FMF
by: Shiran Pinchevski-Kadir, et al.
Published: (2023) -
Arthritis in children with LRBA deficiency - case report and literature review
by: Rotem Semo Oz, et al.
Published: (2019) -
Rilonacept (IL-1 TRAP) for treatment of colchicine resistant familial mediterranean fever (FMF): a randomized, multicenter double-blinded, alternating treatment trial
by: Reiff AO, et al.
Published: (2011) -
Awareness of FMF among Caregivers
by: Belde Kasap Demir, et al.
Published: (2021) -
Anakinra for secondary amyloidosis in an adolescent with FMF and Behcet Disease
by: Bilginer Y, et al.
Published: (2008)